comparemela.com

Latest Breaking News On - Rubicon research - Page 1 : comparemela.com

Global Super Generics Market Report 2024: A $200 Billion

Dublin, May 30, 2024 (GLOBE NEWSWIRE) The

United statesMayne pharmaKashiv biosciencesTesa labtecHikma pharmaceuticalsRubicon researchTechnology landscapeRoute of administrationTaiwan liposome companyTeva pharmaceuticalExela pharma sciencesIntellipharmaceutics internationalAzurity pharmaceuticalsHarrow healthAscendia pharmaceuticalsLatitude pharmaceuticals

General Atlantic pockets $136 mn in twin exit moves from India portfolio

General Atlantic pockets $136 mn in twin exit moves from India portfolio
vccircle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vccircle.com Daily Mail and Mail on Sunday newspapers.

Rubicon researchGeneral atlantic

JNK India IPO subscribed 41% on Day 1, QIBs take lead

JNK India is looking to raise Rs 649.47 crore through the IPO, a fresh issue of shares worth Rs 300 crore and an offer for sale of 84.21 lakh shares worth Rs 349.47 crore

Kotak mutual fundAllianz global investors fundNatixis international fundsGoldman sachsMutual fundRubicon researchInternational fundsGeneral atlanticJnk india ipoJnk india ipo newsJnk india ipo detailsJnk india ipo subscriptionJnk india ipo price bandJnk india ipo closing dateJnk india ipo size

General Atlantic eyes stake sale in Rubicon Research through IPO

The PE firm acquired a 58 percent stake in the pharmaceutical products development company in 2019

Rubicon researchRubicon research financialsRubicon research pvt ltdGeneral atlanticIndia ratingsUbicon researchPrivate equity

Super Generics Market Size Will Reach USD 128 62 Billion to 2031 - Revealed InsightAce Latest Study

/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Super Generics Market –By Therapeutic Area.

South africaUnited kingdomUnited statesSouth koreaKashiv biosciencesAsia pacificTeva treandaMayne pharmaTesa labtecLatitude pharmaceuticalsRoute of administration intravenousTeva pharmaceuticalAzurity pharmaceuticalsExela pharma sciencesRoute of administrationAccord healthcare inc

vimarsana © 2020. All Rights Reserved.